Yuekang Xu

11PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NeonatologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 11, 2026
PROTAC-Engineered Protein/DNA Nanoantigen is a Potent Booster for Dendritic Cell Vaccines in Cancer Immunotherapy.

|Jul 28, 2026
Lactococcal Extracellular Vesicles as In Situ Vaccine Activators in Combination with Doxorubicin for Cancer Therapy.

|May 18, 2026
PMN-MDSCs-derived exosomal S100A9 drives breast cancer progression by enhancing cancer stemness and CXCL5-mediated metastatic potential.

|Feb 27, 2026
Opportunities and challenges for cancer immunotherapy based on antigen cross-presentation.

Peng Liu, Zhe Zhou, Xiaoqiu Su

|Aug 28, 2025
Identification of Two Critical Contact Residues in a Pathogenic Epitope from Tetranectin for Monoclonal Antibody Binding and Preparation of Single-Chain Variable Fragments.

Juncheng Wang, Meng Liu, Rukhshan Zahid

|May 07, 2025
Piceatannol Inhibits the Immunostimulatory Functions of Dendritic Cells and Alleviates Experimental Arthritis.

Luyang Han, Peng Han, Yanbo Zhu

Pageof 2

Frequent Collaborators

5 joint publications

Jinyao Li

2 joint publications

Peng Liu

1 joint publications

Minghui Li

1 joint publications

Jai Rautela